Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis

Alamanos, 2005, Epidemiology of adult rheumatoid arthritis, Autoimmun Rev, 4, 130, 10.1016/j.autrev.2004.09.002

van der Helm-van Mil, 2005, Understanding the genetic contribution to rheumatoid arthritis, Curr Opin Rheumatol, 17, 299, 10.1097/01.bor.0000160780.13012.be

Raza, 2006, Treating very early rheumatoid arthritis, Best Pract Res Clin Rheumatol, 20, 849, 10.1016/j.berh.2006.05.005

Klareskog, 2008, Antibodies to citrullinated proteins in arthritis: pathology and promise, Curr Opin Rheumatol, 20, 300, 10.1097/BOR.0b013e3282fbd22a

Suzuki, 2007, Citrullination by peptidylarginine deiminase in rheumatoid arthritis, Ann N Y Acad Sci, 1108, 323, 10.1196/annals.1422.034

Vossenaar, 2004, Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages, Ann Rheum Dis, 63, 373, 10.1136/ard.2003.012211

Sebbag, 2004, Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis, Joint Bone Spine, 71, 493, 10.1016/j.jbspin.2004.07.004

Szekanecz, 2008, Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?, Clin Rev Allergy Immunol, 34, 26, 10.1007/s12016-007-8022-5

Simon, 1993, The cytokeratin filament-aggregating protein filaggrin is the target of the so-called “antikeratin antibodies,” autoantibodies specific for rheumatoid arthritis, J Clin Invest, 92, 1387, 10.1172/JCI116713

Soos, 2007, Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis, J Rheumatol, 34, 1658

Snir, 2009, Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles, Ann Rheum Dis, 68, 736, 10.1136/ard.2008.091355

Takizawa, 2006, Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids, Ann Rheum Dis, 65, 1013, 10.1136/ard.2005.044743

Vossenaar, 2004, Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin, Arthritis Res Ther, 6, R142, 10.1186/ar1149

Schellekens, 2000, The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide, Arthritis Rheum, 43, 155, 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3

Sebbag, 2006, Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins, Eur J Immunol, 36, 2250, 10.1002/eji.200535790

Vossenaar, 2004, The presence of citrullinated proteins is not specific for rheumatoid synovial tissue, Arthritis Rheum, 50, 3485, 10.1002/art.20584

Alenius, 2006, Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation, Ann Rheum Dis, 65, 398, 10.1136/ard.2005.040998

Nell, 2005, Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis, Ann Rheum Dis, 64, 1731, 10.1136/ard.2005.035691

van Venrooij, 2008, Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis, Ann N Y Acad Sci, 1143, 268, 10.1196/annals.1443.013

Skogh, 2005, Does a positive anti-CCP test identify a distinct arthritis entity?, Arthritis Res Ther, 7, 230, 10.1186/ar1836

van Jaarsveld, 1999, The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis, Clin Exp Rheumatol, 17, 689

Kroot, 2000, The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, Arthritis Rheum, 43, 1831, 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6

Meyer, 2006, Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis, Arthritis Res Ther, 8, R40, 10.1186/ar1896

Nell-Duxneuner, 2009, Autoantibody profiling in patients with very early rheumatoid arthritis — a follow-up study, Ann Rheum Dis

Syversen, 2008, High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study, Ann Rheum Dis, 67, 212, 10.1136/ard.2006.068247

Bukhari, 2007, The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register, Arthritis Rheum, 56, 2929, 10.1002/art.22868

Shovman, 2005, The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis, Clin Dev Immunol, 12, 197, 10.1080/17402520500233510

Huizinga, 2005, Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins, Arthritis Rheum, 52, 3433, 10.1002/art.21385

Kapitany, 2008, Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis, Isr Med Assoc J, 10, 32

Goeb, 2008, Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis, Rheumatology (Oxford), 47, 1208, 10.1093/rheumatology/ken192

de Vries, 2005, Redefining the HLA and RA association: to be or not to be anti-CCP positive, J Autoimmun, 25, 21, 10.1016/j.jaut.2005.09.005

Poor, 2007, Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis, Ann N Y Acad Sci, 1110, 23, 10.1196/annals.1423.004

van der Helm-van Mil, 2007, The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide, Arthritis Rheum, 56, 425, 10.1002/art.22373

Ding, 2009, Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region, Arthritis Rheum, 60, 30, 10.1002/art.24135

Verpoort, 2007, Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles, Arthritis Rheum, 56, 3949, 10.1002/art.23127

Farago, 2008, Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects, Rheumatol Int

Feitsma, 2007, Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients, Rheumatology (Oxford), 46, 1092, 10.1093/rheumatology/kem006

Thabet, 2008, The contribution of Fc gamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA positive rheumatoid arthritis, Ann Rheum Dis

Klareskog, 2006, Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis, Nat Clin Pract Rheumatol, 2, 425, 10.1038/ncprheum0249

Pedersen, 2007, Strong combined gene–environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case–control study in Denmark, Arthritis Rheum, 56, 1446, 10.1002/art.22597